Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Sep;107(1):156–160. doi: 10.1111/j.1476-5381.1992.tb14479.x

The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.

M Linden 1
PMCID: PMC1907603  PMID: 1358381

Abstract

1. The in vitro effects of the beta 2-adrenoceptor agonists (1 x 10(-9)-10(-5) M), terbutaline, salmeterol, and formoterol, on the release of inflammatory mediators, i.e. the eicosanoids leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) and the cytokine interleukin-1 beta (IL-1 beta), were assessed in cultures of human blood monocytes. For comparison, the effects of a 5-lipoxygenase inhibitor, BW A4C (1 x 10(-9)-10(-5) M), and a corticosteroid, budesonide (1 x 10(-10)-10(-5) M) were also examined. Sotalol was used to investigate whether the actions of beta 2-agonists were mediated through beta-adrenoceptors. 2. Terbutaline, like budesonide, had no significant effect on LTB4 release, whereas BW A4C (IC50 = 2 x 10(-8) M) was a potent inhibitor. All concentrations of formoterol approximately halved the LTB4 secretion, whereas high concentrations (1 x 10(-7)-10(-5) M) only, of salmeterol, inhibited release. Only salmeterol, at high concentrations (greater than 1 x 10(-6) M), lowered the secretion of PGE2 in monocyte cultures. Formoterol and salmeterol reduced the secretion of IL-1 beta only at the highest dose (1 x 10(-5) M). In contrast, budesonide (greater than or equal to 1 x 10(-9) M) was a potent suppressant of this secretion. 3. Treatment of monocyte cultures with sotalol (1 x 10(-5) M) did not significantly antagonize the inhibitory effects of salmeterol and formoterol. These results suggest that the inhibitory action of these beta 2-agonists on the release of eicosanoids or IL-1 beta, is not mediated via beta 2-adrenoceptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BULLEN S. S. Correlation of clinical and autopsy findings in 176 cases of asthma. J Allergy. 1952 May;23(3):193–203. doi: 10.1016/0021-8707(52)90017-8. [DOI] [PubMed] [Google Scholar]
  2. Bergstrand H., Björnson A., Blaschke E., Brattsand R., Eklund A., Larsson K., Linden M. Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers. Thorax. 1990 May;45(5):362–368. doi: 10.1136/thx.45.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bitterman P. B., Saltzman L. E., Adelberg S., Ferrans V. J., Crystal R. G. Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest. 1984 Aug;74(2):460–469. doi: 10.1172/JCI111443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blussé van Oud Alblas A., van der Linden-Schrever B., Van Furth R. Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intra-alveolar administration of aerosolized heat-killed BCG. Am Rev Respir Dis. 1983 Aug;128(2):276–281. doi: 10.1164/arrd.1983.128.2.276. [DOI] [PubMed] [Google Scholar]
  5. Chandy K. G., DeCoursey T. E., Cahalan M. D., Gupta S. Ion channels in lymphocytes. J Clin Immunol. 1985 Jan;5(1):1–6. doi: 10.1007/BF00915161. [DOI] [PubMed] [Google Scholar]
  6. Chensue S. W., Kunkel S. L. Arachidonic acid metabolism and macrophage activation. Clin Lab Med. 1983 Dec;3(4):677–694. [PubMed] [Google Scholar]
  7. Church M. K., Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol. 1987 Feb;90(2):421–429. doi: 10.1111/j.1476-5381.1987.tb08972.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DUNNILL M. S. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960 Jan;13:27–33. doi: 10.1136/jcp.13.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dahlberg E., Thalén A., Brattsand R., Gustafsson J. A., Johansson U., Roempke K., Saartok T. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids. Mol Pharmacol. 1984 Jan;25(1):70–78. [PubMed] [Google Scholar]
  10. Fieren M. W., van den Bemd G. J., Ben-Efraim S., Bonta I. L. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. Immunol Lett. 1992 Jan;31(1):85–90. doi: 10.1016/0165-2478(92)90015-g. [DOI] [PubMed] [Google Scholar]
  11. Freeland H. S., Pipkorn U., Schleimer R. P., Bascom R., Lichtenstein L. M., Naclerio R. M., Peters S. P. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar;83(3):634–642. doi: 10.1016/0091-6749(89)90076-6. [DOI] [PubMed] [Google Scholar]
  12. Fuller R. W., O'Malley G., Baker A. J., MacDermot J. Human alveolar macrophage activation: inhibition by forskolin but not beta-adrenoceptor stimulation or phosphodiesterase inhibition. Pulm Pharmacol. 1988;1(2):101–106. doi: 10.1016/s0952-0600(88)80006-1. [DOI] [PubMed] [Google Scholar]
  13. Goldyne M. E., Burrish G. F., Poubelle P., Borgeat P. Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways. J Biol Chem. 1984 Jul 25;259(14):8815–8819. [PubMed] [Google Scholar]
  14. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  15. Henderson W. R., Jr Eicosanoids and lung inflammation. Am Rev Respir Dis. 1987 May;135(5):1176–1185. doi: 10.1164/arrd.1987.135.5.1176. [DOI] [PubMed] [Google Scholar]
  16. Hughes J. M., Seale J. P., Temple D. M. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists. Eur J Pharmacol. 1983 Nov 25;95(3-4):239–245. doi: 10.1016/0014-2999(83)90640-4. [DOI] [PubMed] [Google Scholar]
  17. Knudsen P. J., Dinarello C. A., Strom T. B. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol. 1987 Dec 15;139(12):4129–4134. [PubMed] [Google Scholar]
  18. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980 Mar 1;102(2):344–352. doi: 10.1016/0003-2697(80)90165-7. [DOI] [PubMed] [Google Scholar]
  19. Löfdahl C. G. Basic pharmacology of new long-acting sympathomimetics. Lung. 1990;168 (Suppl):18–21. doi: 10.1007/BF02718108. [DOI] [PubMed] [Google Scholar]
  20. Mattoli S., Mattoso V. L., Soloperto M., Allegra L., Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol. 1991 Apr;87(4):794–802. doi: 10.1016/0091-6749(91)90125-8. [DOI] [PubMed] [Google Scholar]
  21. Page C. P. One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet. 1991 Mar 23;337(8743):717–720. doi: 10.1016/0140-6736(91)90289-2. [DOI] [PubMed] [Google Scholar]
  22. Pawlowski N. A., Kaplan G., Hamill A. L., Cohn Z. A., Scott W. A. Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med. 1983 Aug 1;158(2):393–412. doi: 10.1084/jem.158.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Payne A. N., Garland L. G., Lees I. W., Salmon J. A. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs. Br J Pharmacol. 1988 Jun;94(2):540–546. doi: 10.1111/j.1476-5381.1988.tb11558.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Seggev J. S., Thornton W. H., Jr, Edes T. E. Serum leukotriene B4 levels in patients with obstructive pulmonary disease. Chest. 1991 Feb;99(2):289–291. doi: 10.1378/chest.99.2.289. [DOI] [PubMed] [Google Scholar]
  25. Sporn P. H., Murphy T. M., Peters-Golden M. Glucocorticoids fail to inhibit arachidonic acid metabolism stimulated by hydrogen peroxide in the alveolar macrophage. J Leukoc Biol. 1990 Jul;48(1):81–88. doi: 10.1002/jlb.48.1.81. [DOI] [PubMed] [Google Scholar]
  26. Strieter R. M., Remick D. G., Lynch J. P., 3rd, Genord M., Raiford C., Spengler R., Kunkel S. L. Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis. Am J Respir Cell Mol Biol. 1989 Jul;1(1):57–63. doi: 10.1165/ajrcmb/1.1.57. [DOI] [PubMed] [Google Scholar]
  27. Tannenbaum C. S., Hamilton T. A. Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J Immunol. 1989 Feb 15;142(4):1274–1280. [PubMed] [Google Scholar]
  28. Tateson J. E., Randall R. W., Reynolds C. H., Jackson W. P., Bhattacherjee P., Salmon J. A., Garland L. G. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol. 1988 Jun;94(2):528–539. doi: 10.1111/j.1476-5381.1988.tb11557.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES